mGluR5 : un récepteur à la croisée des chemins thérapeutiques ?

By Flajolet Marc   Wang Hong   Greengard Paul  

Médecine/sciences, Vol. 26, Iss. 8-9, 2011-02 ,pp. : 678-680

Edp Sciences

Access to resources Recommend Favorite

Synthesis and Biological Evaluation of N3‐Alkyl‐Thienopyrimidin‐4‐Ones as mGluR1 Antagonists

By  

BULLETIN OF THE KOREAN CHEMICAL SOCIETY (ELECTRONIC), Vol. 36, Iss. 5, 2015-05 ,pp. : 1439-1451

John Wiley & Sons Inc

Access to resources Recommend Favorite

The selective mGluR5 agonist CHPG protects against traumatic brain injury in vitro and in vivo via ERK and Akt pathway

By            

International Journal of Molecular Medicine, Vol. 29, Iss. 4, 2012-01 ,pp. : 630-636

Spandidos Publications

Access to resources Recommend Favorite

Anti‐absence activity of mGlu1 and mGlu5 receptor enhancers and their interaction with a GABA reuptake inhibitor: Effect of local infusions in the somatosensory cortex and thalamus

By  

EPILEPSIA, Vol. 56, Iss. 7, 2015-07 ,pp. : 1141-1151

John Wiley & Sons Inc

Access to resources Recommend Favorite

Modulation of the TRPV1 Channel: Current Clinical Trials and Recent Patents with Focus on Neurological Conditions

By  

Recent Patents on CNS Drug Discovery, Vol. 8, Iss. 3, 2013-12 ,pp. : 180-204

Bentham Science Publishers

Access to resources Recommend Favorite